GBX2

Chr 2

gastrulation brain homeobox 2

This transcription factor regulates nervous system development and embryonic cell differentiation through sequence-specific DNA binding. Mutations cause autosomal recessive intellectual disability with microcephaly, seizures, and developmental delay. The gene is moderately constrained against loss-of-function variants, and the associated phenotypes primarily affect the nervous system during early development.

OMIMResearchSummary from RefSeq, UniProt
LOFmechanismLOEUF 0.56
Clinical SummaryGBX2
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.71) — some intolerance to loss-of-function variants.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.56LOEUF
pLI 0.713
Z-score 2.37
OE 0.12 (0.040.56)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.40Z-score
OE missense 0.71 (0.620.82)
134 obs / 188.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.12 (0.040.56)
00.351.4
Missense OE0.71 (0.620.82)
00.61.4
Synonymous OE0.78
01.21.6
LoF obs/exp: 1 / 8.4Missense obs/exp: 134 / 188.2Syn Z: 1.62
DN
0.4785th %ile
GOF
0.3391th %ile
LOF
0.77top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GBX2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →